Clinical Trials Logo

Clinical Trial Summary

Anemia is common in patients on hemodialysis (HD) due to lack of erythropoietin (EPO) synthesis and iron deficiency is occurring in HD patients due to chronic blood loss through the dialysis circuit, repeated blood sampling, shortened red blood cell life span and lack of adherence to treatment . Anemia is one of the most important complications that affects morbidity and mortality in chronic kidney disease (CKD) patients. It has significant impacts on those patients such as fatigue, weakness, shortness of breath, decreased quality of life, exercise capacity and physical activity, growth retardation and decreased cognitive functions, left ventricular hypertrophy, and congestive heart failure So, proper management of anemia is very important .


Clinical Trial Description

n/a


Study Design


NCT number NCT05312346
Study type Observational
Source Sohag University
Contact hanan N fawzi, specialist
Phone 01009351849
Email hanan_nagdy_post@med.sohag.edu.eg
Status Not yet recruiting
Phase
Start date April 1, 2022
Completion date April 1, 2023